VLUE vs XBI
iShares MSCI USA Value Factor ETF vs SPDR S&P Biotech ETF
- • VLUE has the lower expense ratio at 0.15% vs 0.35% for XBI.
- • VLUE pays a higher dividend yield (1.40%).
Side-by-side metrics
| Metric | VLUE | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.40% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $10.58B | $10.73B |
YTD return | 41.11% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.20 | 1.10 |
P/E ratio | 17.69 | — |
Last price | $196.76 | $164.01 |
Inception | — | — |
Issuer | iShares | State Street |
VLUE top holdings
| MU | Micron Technology Inc | 24.47% |
| CSCO | Cisco Systems Inc | 4.49% |
| GM | General Motors Co | 3.30% |
| VZ | Verizon Communications Inc | 2.56% |
| T | AT&T Inc | 2.16% |
| BAC | Bank of America Corp | 1.94% |
| F | Ford Motor Co | 1.93% |
| CMCSA | Comcast Corp Class A | 1.71% |
| QCOM | Qualcomm Inc | 1.69% |
| C | Citigroup Inc | 1.63% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About VLUE
VLUE (iShares MSCI USA Value Factor ETF) is US stocks with attractive valuations vs fundamentals. Managed by iShares, the fund carries $10.6B in assets under management, an expense ratio of 0.15%, a dividend yield of 1.40%. Its largest holding is Micron Technology Inc (MU), which represents 24.5% of the portfolio. Real Estate is the fund's largest sector exposure at 1.8%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.